Isoniazid prevention of HIV-associated tuberculosis.

Rangaka, Molebogeng Xheedha; Wilkinson, Robert John

Rangaka, Molebogeng Xheedha; Wilkinson, Robert John.

Afiliación

Rangaka MX; Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa; Centre for Infectious Diseases Epidemiology and Research, University of Cape Town, Observatory 7925, South Africa; Department of Infection and Population Health, University College London, UK; Department of Medicine, University College London, UK; Wolfson Pavilion, Institute of Infectious Disease and Molecular Medicine, Faculty of Heal

Lancet Infect Dis ; 13(10): 825-7, 2013 Oct.

Article en En | MEDLINE | ID: mdl-23954451

Asunto(s)

Antituberculosos/uso terapéutico; Infecciones por VIH/complicaciones; Isoniazida/uso terapéutico; Tuberculosis/diagnóstico; Tuberculosis/prevención & control; Femenino; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Isoniazida / Antituberculosos Tipo de estudio: Risk_factors_studies Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2013 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google